-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
KalVista Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q2 2017 to Q2 2024.
- KalVista Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending July 31, 2024 was -$40.2M, a 50.5% decline year-over-year.
- KalVista Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$89.2M, a 18.6% decline from 2022.
- KalVista Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$75.3M, a 3.68% increase from 2021.
- KalVista Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$78.1M, a 159% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)